Press Enter to search · Esc to close
A long-running U.S. cohort study links weaker odor identification in older adults with later losses in balance, gait and grip — strengthening the case for smell as a low-cost biomarker of aging.
Endocrinologists are quietly rewriting the rulebook — treating diabetes, fatty liver, and heart disease as one slow-burning inflammatory story. Here's what that means for the rest of us.
A new NHANES analysis suggests a simple index pulled from a routine CBC — the Systemic Immune-Inflammatory Index — tracks with mortality risk in metabolic syndrome. Here's what it is, and what it isn't.
Biological-age tests are flooding the longevity scene, but the rulers we use to measure aging — and the muscle loss that comes with it — are getting a hard second look.
A meta-analysis across three large cohorts maps how immune-cell proportions drift with age, sex, and CMV status — and why that should make you skeptical of any 'immune age' panel that ignores who you are.
A new composite index built from C-reactive protein, triglycerides and glucose tracked 7,280 adults for nearly a decade — and outperformed its parts at flagging who progressed.
A 40,000-person Chinese cohort found that a number you can calculate from a routine lipid panel tracks with incident aortic valve calcification — and inflammation explains part of the link.
Two new GeroScience studies suggest that low-cost scalp recordings — paired with machine learning — can flag amnestic MCI and stage Parkinson's with startling accuracy. The catch: it's early.
Three new human studies — a decade-long cohort, a systematic review, and a biomarker case-control trial — sketch an emerging toolkit for spotting dysglycemia before it hardens into disease.
A new analysis of 5,654 American adults links a protein called Klotho to how fast our bodies are actually aging — and it's the kind of signal that nudges Klotho out of the lab and toward your next bloodwork panel.